Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management
Guillermo Garcia‐Manero
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1307-1325
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms
Zdeněk Krejčík, Dávid Kundrát, Jǐŕı Kléma, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Characteristics and Survival Outcomes of Patients with Myelodysplastic Syndromes with Isolated 11q Deletion
Kensuke Takaoka, Rami S. Komrokji, Kelly S. Chien, et al.
Leukemia Research (2025) Vol. 150, pp. 107661-107661
Closed Access | Times Cited: 1
Role of reactive oxygen species in myelodysplastic syndromes
Qiangan Jing, Chaoting Zhou, Junyu Zhang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study
Álex Bataller, Guillermo Montalban‐Bravo, Alexandre Bazinet, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 3, pp. e186-e195
Closed Access | Times Cited: 6
Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms
Pasquale Niscola, Valentina Gianfelici, Marco Giovannini, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1563-1563
Open Access | Times Cited: 6
Nuclear Phospholipids and Signaling: An Update of the Story
Irene Casalin, Eleonora Ceneri, Stefano Ratti, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 713-713
Open Access | Times Cited: 4
Monitoring molecular changes in the management of myelodysplastic syndromes
Nicolas Duployez, Claude Preudhomme
British Journal of Haematology (2024) Vol. 205, Iss. 3, pp. 772-779
Closed Access | Times Cited: 4
Unrelated donor transplantation with post-transplant cyclophosphamide versus ATG for myelodysplastic neoplasms
Yves Chalandon, Diderik-Jan Eikema, Ivan Moiseev, et al.
Blood Advances (2024) Vol. 8, Iss. 18, pp. 4792-4802
Open Access | Times Cited: 4
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study.
Nicolas Stocker, Tamim Alsuliman, Elise Corre, et al.
Clinical Hematology International (2025) Vol. 7, Iss. 1
Open Access
Limited Quality of Life Sacrifice for Optimizing long-term Survival: The Impact of p-ALG Compared to r-ATG in High-Risk Hematological Malignancy Patients Undergoing Matched Sibling Donor Transplantation
Lingyan Yan, Linli Lu, Liwen Wang, et al.
Cytotherapy (2025)
Closed Access
Role of Population Based Studies in Advancing our Knowledge of Myelodysplastic Syndromes
Diego Adrianzen Herrera, Aneta Strumlowska
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access
Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Georgios Petros Barakos, Vasileios Georgoulis, Epameinondas Koumpis, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 19-19
Open Access
VAE-Surv: A novel approach for genetic-based clustering and prognosis prediction in myelodysplastic syndromes
Cesare Rollo, Corrado Pancotti, F Sartori, et al.
Computer Methods and Programs in Biomedicine (2025), pp. 108605-108605
Open Access
MSCs with upregulated lipid metabolism block hematopoietic stem cell differentiation via exosomal CTP-1A in MDS
Chunlai Yin, Xue Yan, Jinyi Ren, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Is TGF-β1 And SMAD-7 Expression At Diagnosis Predictive Of Treatment Response In Patients With Low-Risk Myelodysplastic Syndrome?
Bedrettin ORHAN, Hülya Öztürk Nazlıoğlu, Vildan Özkocaman, et al.
Pathology - Research and Practice (2025), pp. 155839-155839
Closed Access
Comprehensive Analysis of Atypical chronic myeloid leukemia (aCML): Epidemiology, Clinical Features, and Survival Outcomes Based on SEER Database Insights
Zhaoyang Hong, Fan Wang
Leukemia Research Reports (2025) Vol. 23, pp. 100505-100505
Open Access
Association between cigarette smoking, genetic polymorphism and myelodysplasia: A multicentric case-control study
N. Rodriguez, Marta Megido Lahera, José Ramón González Porras, et al.
Medicina Clínica (English Edition) (2025)
Closed Access
The Emerging Role of CD8+ T Cells in Shaping Treatment Outcomes of Patients with MDS and AML
Athanasios Tasis, Theodoros Spyropoulos, Ioannis Mitroulis
Cancers (2025) Vol. 17, Iss. 5, pp. 749-749
Open Access
Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort
Marisa Kometas, Fieke W. Hoff, Jonathan Hyak, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-9
Closed Access
Non-Traumatic Urinary Bladder Hematoma Secondary to Myelodysplastic Syndrome: A Rare Case Report
Devyani Khorate, Shilpa Pai, Pritam Bhatmare
(2025), pp. 181-184
Closed Access
Global, regional, and national burden of myelodysplastic syndromes and myeloproliferative neoplasms, 1990-2021: an analysis from the global burden of disease study 2021
Xinyue Gou, Zhuo Chen, Y. Shangguan
Frontiers in Oncology (2025) Vol. 15
Open Access
Editorial: Allogenic hematopoietic cell transplant in hematological malignancies: controversies and perspective
Salvatore Leotta, Sabrina Giammarco, Jacopo Mariotti
Frontiers in Oncology (2025) Vol. 15
Open Access
The phenomenon of clonal hematopoiesis: etiology, classification and its prognostic role
Евгений Олегович Куневич, М. А. Михалева, О. Б. Крысюк, et al.
Oncohematology (2025) Vol. 20, Iss. 1, pp. 28-54
Open Access
Identification of UBA7 expression downregulation in myelodysplastic neoplasm with SF3B1 mutations
Sael Alatawi, Othman R. Alzahrani, Fuad A. Alatawi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasms
Fuhui Li, Yudi Zhang, Chengwen Li, et al.
Pathology - Research and Practice (2025), pp. 155930-155930
Closed Access
Page 1 - Next Page

Scroll to top